| Nontawan Benja-athonsirikul, | |
|
330 23rd Ave N Ste 604, Nashville, TN 37203-1534 | |
| (615) 986-6039 | |
| Not Available |
| Full Name | Nontawan Benja-athonsirikul |
|---|---|
| Gender | Female |
| Speciality | Obstetrics & Gynecology |
| Location | 330 23rd Ave N Ste 604, Nashville, Tennessee |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104243476 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 288951 (New York) | Secondary |
| 207V00000X | Obstetrics & Gynecology | 68873 (Tennessee) | Primary |
| Entity Name | Rosh Maternal Fetal Medicine Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669708582 PECOS PAC ID: 1052449253 Enrollment ID: O20100510000158 |
News Archive
Xeris Pharmaceuticals, Inc., a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and infusible drug formulations, announced today that Jessica Castle, M.D., an associate professor of medicine in the OHSU School of Medicine and OHSU Harold Schnitzer Diabetes Health Center in Portland, Oregon, is conducting a clinical trial with a dual-hormone artificial pancreas using Xeris' ready-to-use liquid glucagon to evaluate a new closed-loop algorithm.
The U.S. Food and Drug Administration (FDA) on Monday recommended that the H1N1 (swine flu) strain be added to next year's seasonal flu vaccine, "putting an end to separate shots deployed against the pandemic," Bloomberg reports. The FDA committee voted unanimously to make the H1N1 strain one of the three strains included in the shot, according to the news service. "The panel's recommendations are routinely adopted and used to guide vaccine manufacturers," Bloomberg writes (Randall, 2/22).
Sepracor Inc. and Dainippon Sumitomo Pharma Co., Ltd. (DSP) today announce the resignation of Adrian Adams as President and Chief Executive Officer and Director of Sepracor and as Executive Officer of DSP, effective immediately, and the appointment of Saburo Hamanaka as Chairman of Sepracor and Executive Officer of DSP. Sepracor and DSP also announce the planned merger of Sepracor and DSP's subsidiary, Dainippon Sumitomo Pharma America, Inc. (DSPA), to be completed on April 1, 2010, with Sepracor as the surviving company.
On Thursday, an international coalition of public health leaders including CUNY Graduate School of Public Health and Health Policy Dean Ayman El-Mohandes and Senior Scholar Scott Ratzan issued a statement asserting its commitment to vaccine acceptance around the world and to eliminating vaccine-preventable diseases, including childhood diseases such as measles, mumps, and rubella.
The Washington Post: "Unless Democrats can thread a very narrow legislative needle, Republican Scott Brown's upset victory over Martha Coakley in Massachusetts on Tuesday could lead to the collapse of a health-care bill that, only weeks ago, appeared close to becoming law." Though Democratic leaders have tried, in public, to be positive that the health bill "could remain on course," there are increasing concerns that moderates will now "begin to back away from the legislation, fearing its political effects."
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nontawan Benja-athonsirikul, 3024 Business Park Cir, Goodlettsville, TN 37072-3132 Ph: (615) 239-2018 | Nontawan Benja-athonsirikul, 330 23rd Ave N Ste 604, Nashville, TN 37203-1534 Ph: (615) 986-6039 |
News Archive
Xeris Pharmaceuticals, Inc., a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and infusible drug formulations, announced today that Jessica Castle, M.D., an associate professor of medicine in the OHSU School of Medicine and OHSU Harold Schnitzer Diabetes Health Center in Portland, Oregon, is conducting a clinical trial with a dual-hormone artificial pancreas using Xeris' ready-to-use liquid glucagon to evaluate a new closed-loop algorithm.
The U.S. Food and Drug Administration (FDA) on Monday recommended that the H1N1 (swine flu) strain be added to next year's seasonal flu vaccine, "putting an end to separate shots deployed against the pandemic," Bloomberg reports. The FDA committee voted unanimously to make the H1N1 strain one of the three strains included in the shot, according to the news service. "The panel's recommendations are routinely adopted and used to guide vaccine manufacturers," Bloomberg writes (Randall, 2/22).
Sepracor Inc. and Dainippon Sumitomo Pharma Co., Ltd. (DSP) today announce the resignation of Adrian Adams as President and Chief Executive Officer and Director of Sepracor and as Executive Officer of DSP, effective immediately, and the appointment of Saburo Hamanaka as Chairman of Sepracor and Executive Officer of DSP. Sepracor and DSP also announce the planned merger of Sepracor and DSP's subsidiary, Dainippon Sumitomo Pharma America, Inc. (DSPA), to be completed on April 1, 2010, with Sepracor as the surviving company.
On Thursday, an international coalition of public health leaders including CUNY Graduate School of Public Health and Health Policy Dean Ayman El-Mohandes and Senior Scholar Scott Ratzan issued a statement asserting its commitment to vaccine acceptance around the world and to eliminating vaccine-preventable diseases, including childhood diseases such as measles, mumps, and rubella.
The Washington Post: "Unless Democrats can thread a very narrow legislative needle, Republican Scott Brown's upset victory over Martha Coakley in Massachusetts on Tuesday could lead to the collapse of a health-care bill that, only weeks ago, appeared close to becoming law." Though Democratic leaders have tried, in public, to be positive that the health bill "could remain on course," there are increasing concerns that moderates will now "begin to back away from the legislation, fearing its political effects."
› Verified 3 days ago
Barbara H Nylander, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 345 23rd Ave N, Suite 209, Nashville, TN 37203 Phone: 615-329-9082 Fax: 615-329-2423 | |
Dr. Vernita Ann Tucker, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1005 Dr. D. B. Todd Blvd, Nashville, TN 37208 Phone: 615-327-5524 Fax: 615-327-5541 | |
Alexandra Jordan Douglas Phelps, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 3601 The Vanderbilt Clinic, Nashville, TN 37232 Phone: 615-936-2000 | |
Douglas H Brown, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 300 20th Ave N Ste 302, Nashville, TN 37203 Phone: 615-284-2988 Fax: 615-284-2995 | |
Barry S Grimm, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3601 The Vanderbilt Clinic, Nashville, TN 37232 Phone: 615-322-3000 | |
Shannon Marie Madison, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2011 Murphy Ave Ste 601, Nashville, TN 37203 Phone: 615-329-6622 Fax: 615-329-6785 | |
Mckenzie Diane Canon, APRN Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 3601 The Vanderbilt Clinic, Nashville, TN 37232 Phone: 615-322-5000 |